A Comparative Analysis of the Governance and Use of Residual Dried Blood Spots from State Newborn Screening Programs and Neonatal Biobanks

Abstract

In contrast to prior research, which has focused mainly on legislative content, this study aimed to characterize the current governance structures and procedures used by state newborn screening programs in the United States regarding the research use of residual dried blood spots. Content analysis was performed on newborn screening laws, program policies, survey responses, and online material, and was compared to information from two neonatal biobanks. Important differences between newborn screening programs and neonatal biobanks included the types of permissible research with blood spots, the evaluation criteria used for research requests, and characteristics of the research proposal reviewers. These findings can inform ongoing policy conversations with respect to the governance and use of residual dried blood spots.

Keywords

newborn screening dried blood spot policy governance biobank

Get full access to this article

View all access options for this article.

References

AAP Newborn Screening Task Force. (2000). Serving the family from birth to the medical home. Newborn screening: A blueprint for the future—a call for a national agenda on state newborn screening programs. Pediatrics, 106(Suppl 2), 389–422.

Anderson

G. B.

Anderson

P. H.

Dietzen

C. J.

Gildea

L. S.

Meyer

H. M.

Page

A. C.

, & Stras

D. R.

(2011). Alan and Keri Bearder, individually and as parents and natural guardians of Josiah and Alexa Bearder, minors; et al., appellants, vs. State of Minnesota, et al., respondents, A10–0101 (Minnesota Supreme Court 2011). Retrieved from http://caselaw.findlaw.com/mn-supreme-court/1585739.html.

Biery

(2009). Andrea Beleno; et al., appellants, vs. Texas Department of State Health Services, et al., respondents, Case No. 5:2009cv00188 (Texas Western District Court 2009). Retrieved from http://dockets.justia.com/docket/texas/txwdce/5:2009cv00188/353950/.

Brase

(2009). Nine families sue state of Minnesota. Retrieved November 29, 2010, from http://www.cchfreedom.org/cchfphp/37.

Code of Federal Regulations. (2009). Title 45, Part 46, Protection of human subjects, DHHS Regulations U.S.G 46.101. Retrieved from http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.

Cohen

(2010). The government has your baby's DNA. Retrieved November 29, 2010, from http://articles.cnn.com/2010-02-04/health/babydna.government_1_genetic-testing-dna-samples-genetic-diseases?_s=PM:HEALTH.

Department of Health and Human Services-Office of the Secretary. (2011). Human subjects research protections: Enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators. Advanced Notice of Proposed Rulemaking. Retrieved August 22, 2011, from http://www.gpo.gov/fdsys/pkg/FR-2011-07-26/html/2011-18792.htm.

Deschenes

, & Sallee

(2005). Accountability in population biobanking: Comparative approaches. Journal of Law, Medicine & Ethics, 33(1), 40–53.

Drabiak-Syed

(2010). Newborn blood spot banking. Approaches to consent (PredictER Law and Policy Update). Indiana University Center for Bioethics.

10.

Fikac

(2009). State to destroy 4 million newborn blood samples. Retrieved November 29, 2010, from http://www.chron.com/news/houston-texas/article/State-to-destroy-newborns-blood-samples-1599212.php;.

11.

Giannattasio

Caruso

Napoli

Salina

Aloi

Lorini

, & d'Annunzio

(2010). Estimation of genetic risk for type 1 diabetes mellitus in newborns on dried blood spot. Journal of Endocrinological Investigation, 33(6), 406–408.

12.

Goldenberg

A. J.

Hull

S. C.

Botkin

J. R.

, & Wilfond

B. S.

(2009). Pediatric biobanks: Approaching informed consent for continuing research after children grow up. Journal of Pediatrics, 155(4), 578–583.

13.

Haga

S. B.

(2010). Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples. Genetic Testing and Molecular Biomarkers, 14(5), 587–592.

14.

Hannelius

Lindgren

C. M.

Melen

Malmberg

von Dobeln

, & Kere

(2005). Phenylketonuria screening registry as a resource for population genetic studies. Journal of Medical Genetics, 42(10), e60.

15.

Hardin

Finnell

R. H.

Wong

Hogan

M. E.

Horovitz

Shu

, & Shaw

G. M.

(2009). Whole genome microarray analysis, from neonatal blood cards. BMC Genetics, 10, 38.

16.

Hoff

(2008). Long-term follow-up culture in state newborn screening programs. Genetics in Medicine, 10(6), 396–403.

17.

Hoff

Ayoob

, & Therrell

B. L.

(2007). Long-term follow-up data collection and use in state newborn screening programs. Archives of Pediatrics and Adolescent Medicine, 161(10), 994–1000.

18.

Hollegaard

M. V.

Grauholm

Borglum

Nyegaard

Norgaard-Pedersen

Orntoft

(2009). Genome-wide scans using archived neonatal dried blood spot samples. BMC Genomics, 10, 297.

19.

Hollegaard

M. V.

Thorsen

Norgaard-Pedersen

, & Hougaard

D. M.

(2009). Genotyping whole-genome-amplified DNA from 3- to 25-year-old neonatal dried blood spot samples with reference to fresh genomic DNA. Electrophoresis, 30(14), 2532–2535.

20.

Horn

E. J.

Bialick

J. F.

, & Terry

S. F.

(2010). Landscape analysis of registries and biobanks: A tool for disease advocacy organizations to enhance translational research systems. Biopreservation and Biobanking, 8(2), 115–117.

21.

Hudson

N. E.

Minge

, & Muelhlberg

S. L.

(2010). Alan and Keri Bearder, individually and as parents and natural guardians of Josiah and Alexa Bearder, minors; et al., appellants, vs. State of Minnesota, et al., respondents, A10–101 (Minnesota Court of Appeals 2010). Retrieved from caselaw. findlaw.com/mn-court-of-appeals/1536081.html.

22.

Kenner

Lewis

J. A.

Pressler

J. L.

, & Little

C. M.

(2008). Neonatal genetic testing is more than screening. Critical Care Nursing Clinics of North America, 20(2), 233–237, vii.

23.

Lewis

M. H.

Goldenberg

Anderson

Rothwell

, & Botkin

(2011). State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics, 127(4), 703–712.

24.

Mandl

K. D.

Feit

Larson

, & Kohane

I. S.

(2002). Newborn screening program practices in the United States: Notification, research, and consent. Pediatrics, 109(2), 269–273.

25.

McEwen

J. E.

, & Reilly

P. R.

(1994). Stored Guthrie cards as DNA “banks.” American Journal of Human Genetics, 55(1), 196–200.

26.

Mnnesota Department of Health. (2012). Minnesota newborn screening program state laws. Retrieved August 5, 2012, from http://www.health.state.mn.us/divs/phl/newborn/statelaw.html.

27.

Mongoven

, & McGee

(2012). IRB review and public health biobanking: A case study of the Michigan BioTrust for health. IRB: Ethics & Human Research, 34(3), 11–16.

28.

Norgaard-Pedersen

, & Hougaard

D. M.

(2007). Storage policies and use of the Danish Newborn Screening Biobank. Journal of Inherited Metabolic Disease, 30(4), 530–536.

29.

Norgaard-Pedersen

, & Simonsen

(1999). Biological specimen banks in neonatal screening. Acta Paediatrica, Supplement, 88(432), 106–109.

30.

Office Of Human Research Protection. (2008). OHRP—Guidance on research involving coded private information or biological specimens. Retrieved September 27, 2010, from http://www.hhs.gov/ohrp/policy/cdebiol.html.

31.

Olney

R. S.

Moore

C. A.

Ojodu

J. A.

Lindegren

M. L.

, & Hannon

W. H.

(2006). Storage and use of residual dried blood spots from state newborn screening programs. Journal of Pediatrics, 148(5), 618–622.

32.

Rosenbaum

M. B.

(2009). Alan and Keri Bearder, individually and as parents and natural guardians of Josiah and Alexia Bearder, minors; et al., appellants, vs. State of Minnesota, et al., respondents, Court File No. 27-CV-09-5615 (Fourth Judicial Circuit Court, Hennepin County District Court, Minnesota 2009). Retrieved from www.cchfreedom.org/pdf/JudgeRosenbaumOrder113009.pdf.

33.

Rothwell

Anderson

, & Botkin

(2010). Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research. Policy, Politics & Nursing Practice, 11(1), 5–12.

34.

Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. (2010). Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Briefing Paper. U.S. Department of Health and Human Resources. Retrieved from http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence/briefingdriedblood.pdf.

35.

Swede

Stone

C. L.

, & Norwood

A. R.

(2007). National population-based biobanks for genetic research. Genetics in Medicine, 9(3), 141–149.

36.

Tarini

B. A.

Goldenberg

Singer

Clark

S. J.

Butchart

, & Davis

M. M.

(2010). Not without my permission: Parents' willingness to permit use of newborn screening samples for research. Public Health Genomics, 13(3), 125–130.

37.

Therrell

B. L.

Hannon

W. H.

Bailey

D. B.

Goldman

E. B.

Monaco

Norgaard-Pedersen

(2011). Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genetics in Medicine, 13(7), 621–624.

38.

Therrell

B. L.

Hannon

W. H.

Pass

K. A.

Lorey

Brokopp

Eckman

(1996). Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional Networks for Genetic Services. Biochemical and Molecular Medicine, 57(2), 116–124.

39.

Therrell

B. L.

Johnson

, & Williams

(2006). Status of newborn screening programs in the United States. Pediatrics, 117(5 pt 2), S212–252.

40.

Watson

M. S.

Mann

M. Y.

Lloyd-Puryear

M. A.

Rinaldo

Howell

R. R.

, & American College Of Medical Genetics Newborn Screening Expert Group . (2006). Newborn screening: Toward a uniform screening panel and system [executive summary]. Pediatrics, 117(Suppl 3), S296–S307.

41.

Wilson

(2009). Government taking newborn DNA samples: Many ask why they are saving the samples. Retrieved November 29, 2010, from http://www.kxan.com/dpp/news/politics/state_politics/government-taking-newborn-dna-samples.

42.

Winickoff

D. E.

(2003). Governing population genomics: Law, bioethics, and biopolitics in three case studies. Jurimetrics, 43(2), 187–228.